Despite many efforts we still do not have a serum hormone marker or a correct algorithm to choose the optimal starting dose of FSH in patients with low and high ovarian reserve and in those with PCOS and high AMH24,25. The gene discussed is BRD2; the disease is polycystic ovary syndrome.